Cargando…

Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients

Recently published studies have found an impaired immune response after SARS-CoV-2 vaccination in solid organ recipients. However, most of these studies have not assessed immune cellular responses in liver and heart transplant recipients. We prospectively studied heart and liver transplant recipient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera, Sabina, Colmenero, Jordi, Pascal, Mariona, Escobedo, Miguel, Castel, María A., Sole-González, Eduard, Palou, Eduard, Egri, Natalia, Ruiz, Pablo, Mosquera, Mar, Moreno, Asunción, Juan, Manel, Vilella, Anna, Soriano, Alex, Farrero, Marta, Bodro, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800111/ https://www.ncbi.nlm.nih.gov/pubmed/34291552 http://dx.doi.org/10.1111/ajt.16768

Ejemplares similares

Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study
por: Cucchiari, David, et al.
Publicado: (2022)

863. ELISpot-BK virus assay for the assesment of BK virus cell-mediated immunity in kidney recipients
por: Herrera, Sabina, et al.
Publicado: (2023)

A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients
por: Linares, Laura, et al.
Publicado: (2021)

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2021)

Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19
por: Bodro, Marta, et al.
Publicado: (2021)

Disseminated Cryptococcus neoformans infection associated to COVID-19
por: Alegre-González, Diana, et al.
Publicado: (2021)

Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients
por: Santos Bravo, Marta, et al.
Publicado: (2022)

Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir
por: Gonzalez-García, Ruben, et al.
Publicado: (2023)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and review
por: Arana, Carolt, et al.
Publicado: (2022)

Pseudomonas aeruginosa Bloodstream Infection, Resistance, and Mortality: Do Solid Organ Transplant Recipients Do Better or Worse?
por: Herrera, Sabina, et al.
Publicado: (2023)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study
por: Nishikubo, Masashi, et al.
Publicado: (2023)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
por: El Sahly, Hana M, et al.
Publicado: (2022)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss
por: Herrera, Sabina, et al.
Publicado: (2021)

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2023)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
por: Egri, Natalia, et al.
Publicado: (2023)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

A Diet Profiling Algorithm (DPA) to Rank Diet Quality Suitable to Implement in Digital Tools—A Test Study in a Cohort of Lactating Women
por: Alonso-Bernáldez, Marta, et al.
Publicado: (2023)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Breast Milk MicroRNAs Related to Leptin and Adiponectin Function Can Be Modulated by Maternal Diet and Influence Offspring Phenotype in Rats
por: Alonso-Bernáldez, Marta, et al.
Publicado: (2022)

Salvage Treatment with Cefiderocol Regimens in Two Intravascular Foreign Body Infections by MDR Gram-Negative Pathogens, Involving Non-Removable Devices
por: Bodro, Marta, et al.
Publicado: (2021)

Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing
por: López-Aladid, Rubén, et al.
Publicado: (2019)

HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022)

Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
por: Mavrovouniotis, Ilias, et al.
Publicado: (2023)

Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Tylicki, Leszek, et al.
Publicado: (2021)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Inmunología en COVID-19; mucho más allá del diagnóstico de la infección o de la vacunación
por: Egri, Natalia, et al.
Publicado: (2022)

Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination()
por: Egri, Natalia, et al.
Publicado: (2022)

Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients
por: Bulnes-Ramos, Ángel, et al.
Publicado: (2023)

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
por: Reyes-Leiva, David, et al.
Publicado: (2022)

Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
por: Fernández-Ciriza, Leire, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k712ogosv5ibqtlro2be1nkk6o